| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |